Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy

Platinum-based chemotherapy remains the cornerstone of treatment for most non-small cell lung cancer (NSCLC) cases either as maintenance therapy or in combination with immunotherapy. However, resistance remains a primary issue. Our findings point to the possibility of exploiting levels of cell divis...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Commun Biol
Main Authors: Kildey, Katrina, Gandhi, Neha S., Sahin, Katherine B., Shah, Esha T., Boittier, Eric, Duijf, Pascal H. G., Molloy, Christopher, Burgess, Joshua T., Beard, Sam, Bolderson, Emma, Suraweera, Amila, Richard, Derek J., O’Byrne, Kenneth J., Adams, Mark N.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8163776/
https://ncbi.nlm.nih.gov/pubmed/34050247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s42003-021-02136-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados